Nurse management of trastuzumab for patients with breast cancer
Intended for healthcare professionals
Clinical Previous    

Nurse management of trastuzumab for patients with breast cancer

Edward Pace Clinical nurse specialist – Chemotherapy, Plymouth Hospitals NHS Trust, Derriford Hospital, Plymouth
Pauline McIlroy Breast clinical nurse specialist, Beatson Oncology Centre, Glasgow

Modern techniques that enable the molecular characterisation of cancerous tissue have lead to the development of new and more specific therapies. Trastuzumab (Herceptin), a monoclonal antibody drug for the treatment of breast cancer, is one such therapy. Now that trastuzumab is approved for use in the UK, this article will discuss the nursing management of its infusion, possible side effects, aftercare and the psychological needs of the patient being treated with this new drug.

Cancer Nursing Practice. 3, 1, 35-39. doi: 10.7748/cnp2004.02.3.1.35.c108

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more